TY - JOUR
T1 - Prognostic value of intraoperative pleural lavage cytology for non-small cell lung cancer
T2 - The influence of positive pleural lavage cytology results on T classification
AU - Kameyama, Kotaro
AU - Okumura, Norihito
AU - Miyaoka, Etsuo
AU - Asamura, Hisao
AU - Yoshino, Ichiro
AU - Tada, Hirohito
AU - Fujii, Yoshitaka
AU - Nakanishi, Yoichi
AU - Eguchi, Kenji
AU - Mori, Masaki
AU - Kobayashi, Hideo
AU - Sawabata, Noriyoshi
AU - Okumura, Meinoshin
AU - Yokoi, Kohei
PY - 2014/12/1
Y1 - 2014/12/1
N2 - Results A total of 217 patients (5.2%) were PLC-positive, which was significantly associated with a higher incidence of adenocarcinoma and advanced disease. The 5-year survival for patients with positive and negative PLC results were 44.5% and 72.8%, respectively, and this difference in survival was statistically significant (P <.001). Multivariate analysis showed that positive PLC status was an independent factor for a poor prognosis (hazard ratio, 1.57; P <.001). Significant differences in survival were also found between patients with positive and negative PLC results in the same T categories and stages, including T2a, T3, stage IB, and stage IIIA. The IPLCC recommendations adjusted the prognostic differences in all T categories and stages. The significant difference in survival disappeared between the 2 groups in all T categories and stages.Conclusions Our results indicate that a T category upgrade is prognostically adequate for patients who are PLC-positive.Objective Although positive pleural lavage cytology (PLC) has been demonstrated to be closely associated with a poor prognosis for patients with lung cancer, it has not been incorporated into the TNM staging system of the Union for International Cancer Control. The aim of our study was to retrospectively examine the clinical significance of PLC status and illustrate the recommendations of the International Pleural Lavage Cytology Collaborators (IPLCC) in a large national database.
AB - Results A total of 217 patients (5.2%) were PLC-positive, which was significantly associated with a higher incidence of adenocarcinoma and advanced disease. The 5-year survival for patients with positive and negative PLC results were 44.5% and 72.8%, respectively, and this difference in survival was statistically significant (P <.001). Multivariate analysis showed that positive PLC status was an independent factor for a poor prognosis (hazard ratio, 1.57; P <.001). Significant differences in survival were also found between patients with positive and negative PLC results in the same T categories and stages, including T2a, T3, stage IB, and stage IIIA. The IPLCC recommendations adjusted the prognostic differences in all T categories and stages. The significant difference in survival disappeared between the 2 groups in all T categories and stages.Conclusions Our results indicate that a T category upgrade is prognostically adequate for patients who are PLC-positive.Objective Although positive pleural lavage cytology (PLC) has been demonstrated to be closely associated with a poor prognosis for patients with lung cancer, it has not been incorporated into the TNM staging system of the Union for International Cancer Control. The aim of our study was to retrospectively examine the clinical significance of PLC status and illustrate the recommendations of the International Pleural Lavage Cytology Collaborators (IPLCC) in a large national database.
UR - http://www.scopus.com/inward/record.url?scp=84919967359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84919967359&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2014.07.090
DO - 10.1016/j.jtcvs.2014.07.090
M3 - Article
C2 - 25173121
AN - SCOPUS:84919967359
SN - 0022-5223
VL - 148
SP - 2659
EP - 2664
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 6
ER -
